Delivery Order SPE2DB20D3103-SPE2DB25FQ1Z9
Award Date 9/8/25
Potential Completion Date 9/29/25
Potential Value $149K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency has awarded a delivery order valued at $7,451.89 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion by August 11, 2025. The awardee, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Jemperli 500 mg/10 mL vials with a ceiling value of $14,903.78. This is a firm fixed price delivery order under a child contract with no set-aside designation, requiring performance and completion by August 29, 2025. The drug will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office. This...
- The Defense Logistics Agency awarded a $29,807.56 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Jemperli 500 mg/10 ml vials. This is a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and represents a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29.8K to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. The contract was competitively awarded without set-aside provisions and carries a firm fixed-price structure, with an ultimate completion date of September 23, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Jemperli is a specialized pharmaceutical product used in oncology treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $119,230.24 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This firm fixed price, non-set-aside delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal healthcare systems, particularly supporting...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,903.78 on April 24, 2025, for the supply of JEMPERLI 500 mg/10 ml vials. This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by May 15, 2025. The award is funded by the Department of Defense through its Medical Supply Chain organization and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $37,259.45 on September 3, 2025, for the supply of Jemperli 500 mg/10 mL vials. This firm fixed-price, non-set-aside contract is scheduled for completion by September 24, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Jemperli (venetoclax) is a targeted cancer therapy used in the treatment of hematologic malignancies, representing a specialized...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $113,363.90 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of JEMPERLI 500 MG/10 ML VIAL 10ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $34,009.17 firm fixed-price contract is for the supply of the prescription drug JEMPERLI 500 MG/10 ML VIAL 10ML. There is no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $13,984.10 contract is for the delivery of 4563188691 JEMPERLI 500 MG/10 ML VIAL 10ML pharmaceutical products, with a completion date of January 19, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards to supply pharmaceuticals, medical supplies, and...